Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
复制标题
DOI:
10.1371/journal.pone.0164465
复制
发表时间:
2016
期刊:
影响因子:
3.7
通讯作者:
Witt SN
中科院分区:
文献类型:
--
作者:
Wang S;Zhang S;Xu C;Barron A;Galiano F;Patel D;Lee YJ;Caldwell GA;Caldwell KA;Witt SN
We have been investigating the role that phosphatidylethanolamine (PE) and phosphatidylcholine (PC) content plays in modulating the solubility of the Parkinson’s disease protein alpha-synuclein (α-syn) using Saccharomyces cerevisiae and Caenorhabditis elegans. One enzyme that synthesizes PE is the conserved enzyme phosphatidylserine decarboxylase (Psd1/yeast; PSD-1/worms), which is lodged in the inner mitochondrial membrane. We previously found that decreasing the level of PE due to knockdown of Psd1/psd-1 affects the homeostasis of α-syn in vivo. In S. cerevisiae, the co-occurrence of low PE and α-syn in psd1Δ cells triggers mitochondrial defects, stress in the endoplasmic reticulum, misprocessing of glycosylphosphatidylinositol-anchored proteins, and a 3-fold increase in the level of α-syn. The goal of this study was to identify drugs that rescue this phenotype. We screened the Prestwick library of 1121 Food and Drug Administration-approved drugs using psd1Δ + α-syn cells and identified cyclosporin A, meclofenoxate hydrochloride, and sulfaphenazole as putative protective compounds. The protective activity of these drugs was corroborated using C. elegans in which α-syn is expressed specifically in the dopaminergic neurons, with psd-1 depleted by RNAi. Worm populations were examined for dopaminergic neuron survival following psd-1 knockdown. Exposure to cyclosporine, meclofenoxate, and sulfaphenazole significantly enhanced survival at day 7 in α-syn-expressing worm populations whereby 50–55% of the populations displayed normal neurons, compared to only 10–15% of untreated animals. We also found that all three drugs rescued worms expressing α-syn in dopaminergic neurons that were deficient in the phospholipid cardiolipin following cardiolipin synthase (crls-1) depletion by RNAi. We discuss how these drugs might block α-syn pathology in dopaminergic neurons.
登录
查看更多内容
影响因子:
7.7
作者:
Darios, Frederic;Ruiperez, Violeta;Davletov, Bazbek
通讯作者:
Davletov, Bazbek
影响因子:
2.9
作者:
Hansson, MJ;Persson, T;Elmér, E
通讯作者:
Elmér, E
影响因子:
64.5
作者:
LIU, J;FARMER, JD;SCHREIBER, SL
通讯作者:
SCHREIBER, SL
影响因子:
2.5
作者:
Kara E;Lewis PA;Ling H;Proukakis C;Houlden H;Hardy J
通讯作者:
Hardy J
DOI:
10.1073/pnas.0711018105
发表时间:
2008-01-15
影响因子:
11.1
作者:
Hamamichi, Shusei;Rivas, Renee N.;Caldwell, Guy A.
通讯作者:
Caldwell, Guy A.